share_log

宁波美诺华药业股份有限公司关于控股子公司精氨酸培哚普利原料药通过CDE技术审评的公告

Announcement of Ningbo Menova Pharmaceutical Co., Ltd. on the holding subsidiary arginine perindopril API passing the CDE technical review

SZSI ·  Aug 27
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more